The deputy requests to provide "Gleevec" in the south so that cancer patients do not have to travel to Bishkek every month.
{lang_tg}According to Egenberdieva, since 2004, cases of "chronic leukemia" have been registered in Kyrgyzstan, and currently their number exceeds 500, of which 90% are adults and 10% are children. She noted that the supply of "Gleevec" is carried out by a European fund, and the National Center for Oncology and Hematology is the official partner of this humanitarian program.
The deputy stated that patients are forced to take this medication for their entire lives.
Residents of the southern regions, according to her, face the necessity of monthly trips to Bishkek for the medication. These trips cost them between 15,000 to 20,000 soms, and patients are forced to stand in queues and may wait for their medications in the capital for up to a week.
Egenberdieva proposed to organize the distribution of "Gleevec" in the Osh, Jalal-Abad, and Batken regions. She recommended transferring the medication to the Osh Regional Oncology Hospital or the Osh Regional Unified Clinical Hospital, which has a hematology department, to reduce the need for trips to Bishkek.
"This is not just a question of statistics; it is a matter of human life," emphasized the deputy, calling for a protocol directive to the Ministry of Health to address this issue.
In addition, Egenberdieva raised the issue of medical care in the village of Tuzbel in the Jalpak-Tash rural district of the Uzgen region. She pointed out that more than 7,800 people live in this village, yet the local hospital is in an emergency state, and only nurses work there as there are no doctors.
The deputy noted that at night, emergency patients are left without the necessary supervision, and they have to travel to the village of Kurshab, which takes about 45 minutes. This situation becomes especially difficult in winter when additional obstacles arise. {lang_tg} {lang_share_buttons}
Read also:
